RxDoctor Payments Data

Benjamin Yim, MD

Neurological Surgery · Walnut Creek, CANPI 1598176604

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Rapid Medical Ltd at 27.2% of the total. 2025 is the largest year on record at $94,537, more than ten times the $1,776 reported in 2019.

$125,832in general payments, 2019–2025

Across 236 payments — averaging $533.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rapid Medical Ltd$34K
  • Qapel Medical Inc$23K
  • Penumbra, Inc.$18K
  • Stryker$15K
  • Microvention, Inc.$15K
  • Medical Device Business Services, Inc.$10K
  • plus $10K from 18 others
$579,690in research payments, 2019–2025

Across 101 payments — averaging $5739.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$515K
  • Stryker$38K
  • Imperative Care, Inc$27K

What the payments were for

  • Consulting fees$53,82243%
  • Speaking & faculty fees$20,50016%
  • Travel & lodging$41,44833%
  • Food & beverage$10,0628%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,832 in reported general payments places this provider in the 85th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$294,613
Medicare patients
277
Services billed
1,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor47$20,659
ClopidogrelClopidogrel Bisulfate14$133

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →